[1]
Cecere, S.C., Lepori, S., Di Napoli, M., Pisano, C., Rossetti, S., Ventriglia, J., Paciolla, I., Maltese, G., Fontanella, C., Raspagliesi, F. and Lorusso, D. 2017. Olaparib as maintenance treatment in relapsed platinum-sensitive BRCA mutated ovarian cancer: real world experience in two Italian cancer Centers:  . Cancer Breaking News. 5, 1 (Apr. 2017), 25–30. DOI:https://doi.org/10.19156/cbn.2017.0036.